Noguchi-Shinohara M - Search Results

1

Globular-shaped Aβ oligomers have diverse mechanisms for promoting Aβ aggregations with the facilitation of fibril elongation.

Nakano H, Hikishima S, Mori M, Minamikawa J, Muramatsu D, Sakashita Y, Ikeda T, Noguchi-Shinohara M, Teplow DB, Ono K. Nakano H, et al. Among authors: noguchi shinohara m. Neurobiol Dis. 2024 Dec 22:106775. doi: 10.1016/j.nbd.2024.106775. Online ahead of print. Neurobiol Dis. 2024. PMID: 39719197

2

Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.

Ikeda T, Ono K, Elashoff D, Condron MM, Noguchi-Shinohara M, Yoshita M, Teplow DB, Yamada M. Ikeda T, et al. J Alzheimers Dis. 2010;21(1):81-6. doi: 10.3233/JAD-2010-100075. J Alzheimers Dis. 2010. PMID: 20413863

3

Plasma amyloid-β biomarkers are associated with Alzheimer's disease comorbidity in Lewy body disease.

Noguchi-Shinohara M, Murakami H, Sakashita Y, Mori Y, Komatsu J, Muramatsu D, Hikishima S, Ono K. Noguchi-Shinohara M, et al. Parkinsonism Relat Disord. 2023 Jun;111:105445. doi: 10.1016/j.parkreldis.2023.105445. Epub 2023 May 13. Parkinsonism Relat Disord. 2023. PMID: 37201326

4

The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics.

Noguchi-Shinohara M, Ono K. Noguchi-Shinohara M, et al. Int J Mol Sci. 2023 Jun 17;24(12):10215. doi: 10.3390/ijms241210215. Int J Mol Sci. 2023. PMID: 37373401 Free PMC article. Review.

5

Anti-amyloid β Antibody Therapies for Alzheimer's Disease: Association between the Target of Amyloid β Aggregates and the Clinical Efficacy of Anti-amyloid β Antibody.

Noguchi-Shinohara M, Ono K. Noguchi-Shinohara M, et al. Intern Med. 2024 Oct 11. doi: 10.2169/internalmedicine.4604-24. Online ahead of print. Intern Med. 2024. PMID: 39401909 Free article.

6

Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.

Sakai K, Noguchi-Shinohara M, Tanaka H, Ikeda T, Hamaguchi T, Kakita A, Yamada M, Ono K. Sakai K, et al. J Alzheimers Dis. 2023;91(3):1173-1183. doi: 10.3233/JAD-220838. J Alzheimers Dis. 2023. PMID: 36565118

7

Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy.

Watanabe-Nakayama T, Tsuji M, Umeda K, Oguchi T, Konno H, Noguchi-Shinohara M, Kiuchi Y, Kodera N, Teplow DB, Ono K. Watanabe-Nakayama T, et al. Nano Lett. 2023 Jul 12;23(13):6259-6268. doi: 10.1021/acs.nanolett.3c00187. Epub 2023 May 4. Nano Lett. 2023. PMID: 37141711

8

The basis of anti-Aβ antibody therapy: The toxicity of Aβ aggregates and the mechanism of action of anti-Aβ antibodies.

Ono K, Noguchi-Shinohara M, Watanabe-Nakayama T. Ono K, et al. Among authors: noguchi shinohara m. Intern Med. 2024 Oct 4. doi: 10.2169/internalmedicine.4569-24. Online ahead of print. Intern Med. 2024. PMID: 39370248 Free article.

9

Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.

Ono K, Noguchi-Shinohara M, Yoshita M, Naiki H, Yamada M. Ono K, et al. Exp Neurol. 2007 Feb;203(2):579-83. doi: 10.1016/j.expneurol.2006.08.012. Epub 2006 Oct 2. Exp Neurol. 2007. PMID: 17011551

10

Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.

Yamada M, Ono K, Hamaguchi T, Noguchi-Shinohara M. Yamada M, et al. Adv Exp Med Biol. 2015;863:79-94. doi: 10.1007/978-3-319-18365-7_4. Adv Exp Med Biol. 2015. PMID: 26092627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters